as 11-22-2024 3:36pm EST
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | SEATTLE |
Market Cap: | 25.6M | IPO Year: | N/A |
Target Price: | $1.00 | AVG Volume (30 days): | 184.3K |
Analyst Decision: | Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.20 | EPS Growth: | N/A |
52 Week Low/High: | $0.18 - $0.94 | Next Earning Date: | 11-15-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
KNW Breaking Stock News: Dive into KNW Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Business Wire
8 days ago
Business Wire
8 days ago
Business Wire
a month ago
Business Wire
a month ago
Business Wire
2 months ago
Business Wire
2 months ago
Business Wire
3 months ago
The information presented on this page, "KNW Know Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.